title: Catecholamine depletion modulates serum LH levels, GAD67 mRNA, and GABA synthesis in the goldfish.
abstract: It is established that dopamine inhibits while GABA stimulates LH release in goldfish. In this study, we examine dopaminergic regulation of GABAergic activity in the hypothalamus of early recrudescent female goldfish (Carassius auratus). We utilize a unique technique that permits concomitant quantification and correlation of in vivo GAD65 and GAD67 mRNA with GABA synthesis rate in response to decreased dopamine levels. Catecholamine depletion was achieved by treatment with alpha-methyl-para-tyrosine methyl ester (alphaMPT; 240 microg/g body weight), an inhibitor of tyrosine hydroxylase. Endogenous GABA levels were increased by intraperitoneal administration of gamma-vinyl GABA (GVG; 300 microg/g body weight), an inhibitor of the GABA catabolic enzyme GABA transaminase. Dual treatment of GVG+alphaMPT increased serum LH levels 4-fold. However, LH mRNA levels in the pituitary remained stable, suggesting that treatments affected secretion and not synthesis. In the hypothalamus, GABA synthesis rates increased 30% in response to alphaMPT treatment. This was correlated (r=0.61; p<0.05) to increased levels of GAD67 mRNAs but not GAD65 (r=0.14; p>0.05). These observations suggest that catecholamines inhibit GABA synthesis in the goldfish hypothalamus through isoform specific regulation of GAD67.
authors.affiliation: Department of Biology, Centre for Advanced Research in Environmental Genomics (CAREG), MacDonald Hall, University of Ottawa, Ottawa, Ont., Canada K1N 6N5.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Hibbert
authors.forename: Irene
authors.initials: I
authors.lastname: Fung
authors.forename: Rebecca
authors.initials: R
authors.lastname: McAuley
authors.forename: Marwan
authors.initials: M
authors.lastname: Samia
authors.forename: Vance
authors.initials: V
authors.lastname: Trudeau
mesh_terms: D000818:Animals; D015152:Blotting, Northern / Q000662:veterinary; D004298:Dopamine / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005786:Gene Expression Regulation; D005968:Glutamate Decarboxylase / Q000096:biosynthesis* / Q000235:genetics; D006054:Goldfish / Q000235:genetics / Q000378:metabolism*; D007031:Hypothalamus / Q000378:metabolism; D007527:Isoenzymes / Q000096:biosynthesis* / Q000235:genetics; D007986:Luteinizing Hormone / Q000097:blood* / Q000235:genetics; D008781:Methyltyrosines / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000662:veterinary; D020888:Vigabatrin / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000096:biosynthesis* / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D007527:Isoenzymes; D008781:Methyltyrosines; D012333:RNA, Messenger; C022260:alpha-methyltyrosine methyl ester; D005680:gamma-Aminobutyric Acid; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D005968:Glutamate Decarboxylase; C402565:glutamate decarboxylase 1; D020888:Vigabatrin; D004298:Dopamine